Literature DB >> 17432550

Epidemiology of prostate cancer.

Vera Nelen1.   

Abstract

Prostate cancer is one of the most important cancers in men. With a worldwide incidence of 25.3 per 100,000 it is the second most common cancer in men, with large differences between countries. Important clues on risk factors remain to be found. Age, genetic factors and environmental influences have been studied. Incidence has been increasing over the last few decades, largely due to early detection procedures. The mortality rate of 8.1 per 100,000 mainly affects men at older ages; increases in this rate over time and differences between countries are markedly smaller than for incidence. For the future, prostate cancer will remain an important and--through evolutions in incidence and demography--growing health problem.

Entities:  

Mesh:

Year:  2007        PMID: 17432550     DOI: 10.1007/978-3-540-40901-4_1

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  12 in total

1.  Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Authors:  Jill S Barnholtz-Sloan; Xiaowei Guan; Charnita Zeigler-Johnson; Neal J Meropol; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

Review 2.  Risk factors for prostate cancer.

Authors:  Amit R Patel; Eric A Klein
Journal:  Nat Clin Pract Urol       Date:  2009-02

3.  The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors.

Authors:  Sadi Turkan; Faruk Doğan; Ozan Ekmekçioğlu; Aslıhan Çolak; Mehmet Kalkan; Çoşkun Şahin
Journal:  Turk J Urol       Date:  2016-09

4.  CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis.

Authors:  D Eyman; M Damodarasamy; S R Plymate; M J Reed
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

5.  [Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance?].

Authors:  M May; R Kalisch; B Hoschke; T Juretzek; F Wagenlehner; S Brookman-Amissah; I Spivak; K-P Braun; W Bär; C Helke
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

6.  mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.

Authors:  Sujit K Bhutia; Swadesh K Das; Timothy P Kegelman; Belal Azab; Rupesh Dash; Zhao-Zhong Su; Xiang-Yang Wang; Federica Rizzi; Saverio Bettuzzi; Seok-Geun Lee; Paul Dent; Steven Grant; David T Curiel; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

7.  SNP-SNP interactions as risk factors for aggressive prostate cancer.

Authors:  Venkatesh Vaidyanathan; Vijay Naidu; Nishi Karunasinghe; Anower Jabed; Radha Pallati; Gareth Marlow; Lynnette R Ferguson
Journal:  F1000Res       Date:  2017-05-03

8.  Ureteral Metastasis Secondary to Prostate Cancer: A Case Report.

Authors:  I Morales; C Bassa; A Pavlovic; C Morales
Journal:  Urol Case Rep       Date:  2015-12-29

9.  Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

Authors:  Aime M Gloi; Robert Buchanan
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

10.  Resveratrol-loaded PLGA nanoparticles mediated programmed cell death in prostate cancer cells.

Authors:  Anmar M Nassir; Naiyer Shahzad; Ibrahim A A Ibrahim; Iqbal Ahmad; Shadab Md; Mohammad R Ain
Journal:  Saudi Pharm J       Date:  2018-03-15       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.